Oftalmología en imágenes. Iris hamartomas
Mejía, Luis Fernando.
Rev. Soc. Colomb. Oftalmol
; 49(4): 324-324, 2016. graf.
Artículo en Español | LILACS, COLNAL | ID: biblio-905694
Documentos relacionados
Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.
Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation.
Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
The Neurofibromatoses.
Caveat mammalian target of rapamycin (mTOR) revisited: Neurofibromatosis.
Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.
Population-specific facial traits and diagnosis accuracy of genetic and rare diseases in an admixed Colombian population.
[Segmental neurofibromatosis].